HTLF Bank Buys New Position in Humana Inc. (NYSE:HUM)

HTLF Bank bought a new position in Humana Inc. (NYSE:HUM) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 833 shares of the insurance provider’s stock, valued at approximately $381,000.

A number of other institutional investors and hedge funds have also recently modified their holdings of the business. Rakuten Securities Inc. bought a new position in Humana during the fourth quarter worth $25,000. Sunbelt Securities Inc. bought a new stake in Humana in the 1st quarter valued at about $28,000. Gradient Investments LLC increased its position in Humana by 200.0% in the 4th quarter. Gradient Investments LLC now owns 60 shares of the insurance provider’s stock valued at $27,000 after buying an additional 40 shares in the last quarter. Nvwm LLC raised its stake in Humana by 41.0% during the 3rd quarter. Nvwm LLC now owns 86 shares of the insurance provider’s stock worth $42,000 after buying an additional 25 shares during the period. Finally, Operose Advisors LLC bought a new position in Humana in the third quarter worth approximately $56,000. 92.38% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

A number of equities analysts recently issued reports on HUM shares. TD Cowen cut their target price on Humana from $427.00 to $396.00 and set a “buy” rating on the stock in a report on Tuesday, April 2nd. The Goldman Sachs Group dropped their price target on shares of Humana from $450.00 to $385.00 and set a “buy” rating on the stock in a research report on Wednesday, April 3rd. Truist Financial reissued a “hold” rating and set a $550.00 price objective on shares of Humana in a report on Friday, January 19th. TheStreet lowered Humana from a “b” rating to a “c+” rating in a report on Monday, January 8th. Finally, UBS Group reiterated a “neutral” rating and set a $370.00 price target (down previously from $530.00) on shares of Humana in a report on Friday, January 26th. Eleven equities research analysts have rated the stock with a hold rating and nine have issued a buy rating to the company’s stock. According to MarketBeat, the company has an average rating of “Hold” and an average price target of $465.42.

Humana Price Performance

Humana stock opened at $328.33 on Friday. The company has a debt-to-equity ratio of 0.63, a current ratio of 1.59 and a quick ratio of 1.59. Humana Inc. has a one year low of $299.23 and a one year high of $541.21. The firm has a market capitalization of $39.61 billion, a P/E ratio of 16.57, a PEG ratio of 1.90 and a beta of 0.45. The business has a fifty day moving average price of $330.40 and a 200-day moving average price of $400.99.

Humana (NYSE:HUM) last issued its earnings results on Thursday, January 25th. The insurance provider reported ($0.11) EPS for the quarter, missing the consensus estimate of $0.76 by ($0.87). Humana had a return on equity of 19.44% and a net margin of 2.34%. The company had revenue of $26.46 billion during the quarter, compared to the consensus estimate of $25.47 billion. During the same quarter in the prior year, the business earned $1.62 EPS. The firm’s revenue for the quarter was up 17.9% compared to the same quarter last year. As a group, equities research analysts forecast that Humana Inc. will post 16.06 EPS for the current year.

Humana Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, July 26th. Shareholders of record on Friday, June 28th will be paid a $0.885 dividend. This represents a $3.54 annualized dividend and a yield of 1.08%. The ex-dividend date is Friday, June 28th. Humana’s dividend payout ratio is presently 17.86%.

Insider Buying and Selling at Humana

In other Humana news, Director Jorge S. Mesquita acquired 545 shares of the stock in a transaction that occurred on Tuesday, February 20th. The shares were bought at an average price of $367.09 per share, for a total transaction of $200,064.05. Following the completion of the transaction, the director now owns 2,578 shares of the company’s stock, valued at approximately $946,358.02. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Insiders own 0.32% of the company’s stock.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.